Stock Events

Stock Events

Nanologix 

$0
6
+$0+0% Wednesday 21:00

Statistics

Day High
0
Day Low
0
52W High
0.04
52W Low
0
Volume
100
Avg. Volume
39,070
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

30SepExpected
Q4 2012
Q1 2013
Q2 2013
Q3 2013
Q4 2013
Q1 2014
Q2 2014
-0
-0
-0
-0
Expected EPS
N/A
Actual EPS
-0.002

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NNLX. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Thermo Fisher Scientific
TMO
Mkt Cap182.57B
Thermo Fisher Scientific Inc. offers a broad range of products for diagnostics and research, directly competing with Nanologix's diagnostic solutions.
Becton Dickinson
BDX
Mkt Cap55.98B
Becton, Dickinson and Company provides diagnostic instruments and reagents, competing in the same space as Nanologix's diagnostic technologies.
Hologic
HOLX
Mkt Cap16.89B
Hologic, Inc. specializes in diagnostics, medical imaging systems, and surgical products, competing with Nanologix in the diagnostics market.
Qiagen NV
QGEN
Mkt Cap8.46B
Qiagen N.V. offers technologies and products for diagnostics and research, making it a competitor in the molecular diagnostics field.
Guardant Health
GH
Mkt Cap12.31B
Guardant Health, Inc. focuses on liquid biopsies and cancer diagnostics, competing with Nanologix's efforts in rapid diagnostic technologies.
Danaher
DHR
Mkt Cap135.26B
Danaher Corporation operates in the diagnostics and research sector, directly competing with Nanologix's diagnostic solutions.
Pacific Biosciences of California
PACB
Mkt Cap404.68M
Pacific Biosciences of California, Inc. provides sequencing systems, competing in the broader diagnostics and research market.
Illumina
ILMN
Mkt Cap19.48B
Illumina, Inc. offers sequencing and array-based solutions for genetic analysis, competing in the diagnostics and research field.
Fulgent Genetics
FLGT
Mkt Cap525.3M
Fulgent Genetics, Inc. provides comprehensive genetic testing, directly competing with Nanologix's focus on rapid and innovative diagnostic solutions.

About

NanoLogix, Inc., a biotechnology company, provides live cell and rapid diagnostics test kits that detects viable bacteria and other microorganisms. The company's products include BioNanoPore kit, which employs a water permeable membrane that works with organic and inorganic molecules, as well as proteins; and FlatPack Petri Plates that are used for the isolation and cultivation of various fastidious and non-fastidious microorganisms, as well as displays growth of aerobic and anaerobic microorganisms. Its products are used in medical, national defense, homeland security, pharmaceutical, industrial, veterinary, and environmental testing applications. The company sells its products to established medical and scientific entities, including laboratories, medical institutions, universities, businesses, and research establishments. NanoLogix, Inc. is based in Hubbard, Ohio.
Show more...
CEO
Mr. Bret T. Barnhizer
Country
US
ISIN
US6300761078

Listings

OTC Link
US
NNLX

0 Comments

Share your thoughts

FAQ

What is Nanologix stock price today?▼
The current price of NNLX is $0 USD — it has increased by +0% in the past 24 hours. Watch Nanologix stock price performance more closely on the chart.
What is Nanologix stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Nanologix stocks are traded under the ticker NNLX.
What were Nanologix earnings last quarter?▼
NNLX earnings for the last quarter are -0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
In which sector is Nanologix located?▼
Nanologix operates in the Health Care sector.
When did Nanologix complete a stock split?▼
Nanologix has not had any recent stock splits.
Where is Nanologix headquartered?▼
Nanologix is headquartered in Hubbard, US.